15 Best NASDAQ Dividend Stocks To Buy
The NASDAQ, heavily comprised of technology stocks, has been on a consistent upward trajectory for some years.
Gilead Sciences Inc. (GILD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 103,025 | $9,516,376 | +1% | 0.58% |
| 2. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 14,243 | $1,315,626 | -3% | 0.49% |
| 3. | Ayrshire Capital Management John Nevin Jr. | 5,415 | $500,184 | +1% | 0.24% |
| 4. | Bourgeon Capital John Zaro | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.92 | 10,000 | Director | 88,173 | 2015-02-06 | Filing | |
| $43.05 | 10,000 | Director | 69,458 | 2013-02-28 | Filing | |
| $44.00 | 10,000 | Director | 26,097 | 2012-02-22 | Filing | |
| $38.60 | 8,704 | Director | 12,800 | 2010-05-04 | Filing | |
| $38.59 | 4,096 | Director | 4,096 | 2010-05-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $91.35 | 2,500 | Officer | 129,873 | 2025-01-15 | Filing | |
| $91.96 | 8,500 | Officer | 132,373 | 2024-12-16 | Filing | |
| $92.76 | 127,930 | Officer | 138,919 | 2024-11-29 | Filing | |
| $92.77 | 120,715 | Officer | 266,849 | 2024-11-29 | Filing | |
| $92.00 | 10,399 | Officer | 80,801 | 2024-11-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 122,793,011 | $9,947,461,818 | 0.25% | |
| 2. | 111,822,428 | $9,058,734,893 | 0.19% | |
| 3. | 83,364,123 | $6,753,349,838 | 1.2% | |
| 4. | 59,657,126 | $4,832,824,186 | 1.18% | |
| 5. | 59,536,425 | $4,823,045,789 | 0.23% |
News See All
Here’s Why TCW Relative Value Large Cap Fund Exited its Position in Gilead Sciences (GILD)
TCW Funds, an investment management company, released its “TCW Relative Value Large Cap Fund” Q3 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, U.S.
Gilead Sciences, Inc. (GILD): A Bull Case Theory
We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc.
Top 20 Dividend Stocks of 2024
Macroeconomic factors have weighed on US stocks in the final days of the year, with the broader market declining by over 1% in the past week.
13 Best Pharma Dividend Stocks To Buy In 2024
The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, reflecting a shift toward smaller, more strategic transactions.
Jim Cramer Talked About These 8 Stocks
Jim Cramer, host of Mad Money, recently shared some investment wisdom drawn from his four decades of experience.
Gilead Sciences (GILD) Made Big Announcements in Q3
Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the same can be downloaded here.
Gilead Sciences, Inc. (NASDAQ:GILD) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to Gilead's Third Quarter 2024 Earnings Conference Call. My name is Rebecca, and I'll be your host for today.
10 Best Pharma Stocks To Buy Right Now
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of new treatments, and design...
Goldman Sachs' Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE
As the fourth quarter of 2024 settles in, the narrative surrounding stocks on Wall Street is starting to shift.
Billionaire Hedge Funds
